{"id":6609,"date":"2025-05-12T11:56:13","date_gmt":"2025-05-12T06:26:13","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=6609"},"modified":"2025-05-12T11:56:13","modified_gmt":"2025-05-12T06:26:13","slug":"stocks-to-buy-today-may-12th-2025","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/news\/stocks-to-buy-today-may-12th-2025\/","title":{"rendered":"Stocks to Buy Today: May 12, 2025"},"content":{"rendered":"

[vc_section el_id=”blog-inner-layout”][vc_row overlay_dotted=””][vc_column el_class=”blog_primary”][vc_row_inner][vc_column_inner][vc_column_text css=””]Following the ceasefire between India and Pakistan and positive trade progress between the US and China, the market performed as expected today. The <\/span>Sensex<\/span><\/a> opened with a gain of 2,238 points, while the <\/span>Nifty 50<\/span><\/a> rose by 692 points. What\u2019s worth observing in today\u2019s session is how Foreign Institutional Investors (FIIs) transact, as their continuous buying over the past 16 sessions, except on Friday, has added momentum to the overall market. Amid all the movements in the market, two stocks worth tracking in today’s session are Cohance Lifesciences Ltd and Rainbow Children’s Medicare Ltd.<\/span><\/p>\n

<\/span>Stocks to Buy Today\u00a0<\/b><\/span><\/h2>\n

Here is the curated stock you may track in today\u2019s trading session:<\/span><\/p>\n

<\/span>Cohance Lifesciences Ltd. (NSE: SUVENPHAR)<\/b><\/span><\/h3>\n

Cohance Lifesciences has recently amalgamated with <\/span>Suven Pharmaceuticals<\/span><\/a> after the National Company Law Tribunal\u2019s (NCLT) approval. According to the terms and conditions of this corporate event, Suven Pharma will offer 11 shares for every 295 Cohance Lifesciences shares. With this merger, the combined entity aims to scale up modalities such as Oligonucleotides and ADCs, strengthen the value chain, improve partnerships with the existing customer base, and achieve a target of $1 billion in the coming years.<\/span><\/p>\n

After the amalgamation was completed, Cohance Lifesciences\u2019 share price dropped around 7.59% over a week. However, its long-term performance on the price chart remains impressive, with 52-week returns standing at 62.56%.<\/span><\/p>\n

Key details of Cohance Lifesciences Ltd. stocks:<\/span><\/p>\n\n\n\n\n\n\n\n
Closing Price (as of May 09, 2025)<\/span><\/td>\n\u20b91077.80<\/span><\/td>\n<\/tr>\n
Trading Volume<\/span><\/td>\n1,52,170<\/span><\/td>\n<\/tr>\n
Company Type<\/span><\/td>\nMidcap<\/span><\/a>\u00a0<\/span><\/td>\n<\/tr>\n
Market Cap<\/span><\/td>\n\u20b940,747.23 crores\u00a0<\/span><\/td>\n<\/tr>\n
Beta<\/span><\/td>\n1.34<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Rainbow Children’s Medicare Ltd. (NSE: RAINBOW)<\/b><\/span><\/h3>\n

Rainbow Children Medicare<\/span><\/a> provides healthcare services. The company operates 16 hospitals and three clinics in six cities, specialising in obstetrics, paediatrics, and gynaecology services. Its healthcare facilities have 1,655 beds.\u00a0<\/span><\/p>\n

According to the company’s Chairman, Mr. Ramesh Kancharla, Rainbow Children Medicare plans to expand its operations by acquiring two hospitals: one in Hyderabad with a bed capacity of 75 and another in the Northeast with 150 beds. Additionally, the company aims to increase its existing bed capacity by 1,000 by 2027.<\/span><\/p>\n

The company is also expecting to achieve a profit margin of 15% in the coming months, up from its current 10%.<\/span><\/p>\n

Key details of Rainbow Children’s Medicare Ltd. stocks:<\/span><\/p>\n\n\n\n\n\n\n\n
Closing Price (as of May 09, 2025)<\/span><\/td>\n\u20b91343.50<\/span><\/td>\n<\/tr>\n
Trading Volume<\/span><\/td>\n16,781<\/span><\/td>\n<\/tr>\n
Company Type<\/span><\/td>\nSmallcap<\/span><\/a>\u00a0<\/span><\/td>\n<\/tr>\n
Market Cap<\/span><\/td>\n\u20b913,783 crores\u00a0<\/span><\/td>\n<\/tr>\n
Beta<\/span><\/td>\n0.41<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Conclusion<\/b><\/span><\/h2>\n

Stock market trading carries significant risk due to constant price fluctuations, economic shifts, and unpredictable global events. There is no guarantee of positive returns, regardless of the stock you choose to trade. To manage this risk, it is important to diversify your portfolio, set stop-loss orders, and avoid emotional trading. Conducting proper research and using technical indicators like RSI and Moving Averages can also help you make informed decisions. Always invest within your risk tolerance and follow a clear strategy to minimise losses and protect your capital in volatile markets.<\/span><\/p>\n

Just starting out with investing? Begin your <\/span>stock market<\/span><\/a> journey by <\/span>opening a Demat Account<\/span><\/a> with Torus Digital today.<\/span><\/p>\n

 [\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_id=”share_rating”][vc_column_inner width=”1\/2″][vc_column_text css=””]<\/p>\n

Rate this article<\/h6>\n